An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo
Cell Reports · 2024-11 · 43 (11) · 114929
DOI: 10.1016/j.celrep.2024.114929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Nian E Zhou und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77840, USA. Hauptthemen laut MEDLINE: Virus Replication, SARS-CoV-2, Antiviral Agents, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases Division of Intramural Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77840, USA.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Calibr-Skaggs Institute for Innovative Medicine, La Jolla, CA 92037, USA.
- Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- Japan Agency for Medical Research and Development
- Welch Foundation
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- North Carolina General Assembly
Zitieren
APA
Zhou, N. E., Tang, S., Bian, X., Parai, M. K., Krieger, I. V., Flores, A., Jaiswal, P. K., Bam, R., Wood, J. L., Shi, Z., Stevens, L. J., Scobey, T., Diefenbacher, M. V., Moreira, F. R., Baric, T. J., Acharya, A., Shin, J., Rathi, M. M., Wolff, K. C., …, & Sacchettini, J. C. (2024). An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Reports, 43(11), 114929. https://doi.org/10.1016/j.celrep.2024.114929
Vancouver
Zhou NE, Tang S, Bian X, Parai MK, Krieger IV, Flores A, et al. An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo. Cell Reports. 2024;43(11):114929. doi:10.1016/j.celrep.2024.114929
BibTeX
@article{Zhou2024,
author = {Zhou, Nian E and Tang, Su and Bian, Xuelin and Parai, Maloy K and Krieger, Inna V and Flores, Armando and Jaiswal, Pradeep K and Bam, Radha and Wood, Jeremy L and Shi, Zhe and Stevens, Laura J and Scobey, Trevor and Diefenbacher, Meghan V and Moreira, Fernando R and Baric, Thomas J and Acharya, Arjun and Shin, Joonyoung and Rathi, Manish M and Wolff, Karen C and Riva, Laura and Bakowski, Malina A and McNamara, Case W and Catanzaro, Nicholas J and Graham, Rachel L and Schultz, David C and Cherry, Sara and Kawaoka, Yoshihiro and Halfmann, Peter J and Baric, Ralph S and Denison, Mark R and Sheahan, Timothy P and Sacchettini, James C},
title = {An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {11},
pages = {114929},
doi = {10.1016/j.celrep.2024.114929}
}
EUVIMED